"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT03840343","Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease",,"Recruiting","No Results Available","Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency","Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose","Adverse Events|Kidney Function","Mayo Clinic|Regenerative Medicine Minnesota","All","45 Years to 75 Years   (Adult, Older Adult)","Phase 1","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","18-002423|RMM 091718 CT 001","October 23, 2019","December 2024","December 2025","February 15, 2019",,"March 15, 2022","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03840343"
2,"NCT05191381","Immune Modulation by Exosomes in COVID-19","IMECOV19","Recruiting","No Results Available","COVID-19|Critical Illness|Hypercytokinemia|Lung Fibrosis","Biological: Application of exosomes in a whole blood assay","Cytokine profile in supernatants|Immune phenotyping|Genetic predisposition to hyperinflammation","University of Ulm","All","18 Years to 90 Years   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Lung fibrosis in COVID19","December 22, 2021","July 31, 2022","December 31, 2022","January 13, 2022",,"February 2, 2022","Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine, Ulm, Germany",,"https://ClinicalTrials.gov/show/NCT05191381"
